Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Autologous mesenchymal stem cells: Hope for patients with multiple system atrophy?

Krismer F, Poewe W, Seppi K.

Neurology. 2019 May 31. pii: 10.1212/WNL.0000000000007721. doi: 10.1212/WNL.0000000000007721. [Epub ahead of print] No abstract available.

PMID:
31152012
2.

Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study).

Peball M, Werkmann M, Ellmerer P, Stolz R, Valent D, Knaus HG, Ulmer H, Djamshidian A, Poewe W, Seppi K.

J Neural Transm (Vienna). 2019 May 25. doi: 10.1007/s00702-019-02021-z. [Epub ahead of print]

PMID:
31129719
3.

Gait and postural disorders in parkinsonism: a clinical approach.

Raccagni C, Nonnekes J, Bloem BR, Peball M, Boehme C, Seppi K, Wenning GK.

J Neurol. 2019 May 22. doi: 10.1007/s00415-019-09382-1. [Epub ahead of print] Review.

PMID:
31119450
4.

A critique of the second consensus criteria for multiple system atrophy.

Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Höglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK; Movement Disorder Society Multiple System Atrophy Study Group.

Mov Disord. 2019 Apr 29. doi: 10.1002/mds.27701. [Epub ahead of print] No abstract available.

PMID:
31034671
5.

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.

van Eimeren T, Antonini A, Berg D, Bohnen N, Ceravolo R, Drzezga A, Höglinger GU, Higuchi M, Lehericy S, Lewis S, Monchi O, Nestor P, Ondrus M, Pavese N, Peralta MC, Piccini P, Pineda-Pardo JÁ, Rektorová I, Rodríguez-Oroz M, Rominger A, Seppi K, Stoessl AJ, Tessitore A, Thobois S, Kaasinen V, Wenning G, Siebner HR, Strafella AP, Rowe JB.

Alzheimers Dement (Amst). 2019 Apr 2;11:301-309. doi: 10.1016/j.dadm.2019.01.011. eCollection 2019 Dec.

6.

Characterizing advanced Parkinson's disease: OBSERVE-PD observational study results of 2615 patients.

Fasano A, Fung VSC, Lopiano L, Elibol B, Smolentseva IG, Seppi K, Takáts A, Onuk K, Parra JC, Bergmann L, Sail K, Jalundhwala Y, Pirtosek Z.

BMC Neurol. 2019 Apr 2;19(1):50. doi: 10.1186/s12883-019-1276-8.

7.

Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.

Krismer F, Seppi K, Göbel G, Steiger R, Zucal I, Boesch S, Gizewski ER, Wenning GK, Poewe W, Scherfler C.

Mov Disord. 2019 Mar 28. doi: 10.1002/mds.27669. [Epub ahead of print]

PMID:
30919495
8.

Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease.

Fanciulli A, Goebel G, Lazzeri G, Scherfler C, Gizewski ER, Granata R, Kiss G, Strano S, Colosimo C, Pontieri FE, Kaufmann H, Seppi K, Poewe W, Wenning GK.

Mov Disord. 2019 Mar;34(3):440-441. doi: 10.1002/mds.27635. Epub 2019 Feb 20. No abstract available.

PMID:
30788854
9.

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.

Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C; the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee.

Mov Disord. 2019 Feb;34(2):180-198. doi: 10.1002/mds.27602. Epub 2019 Jan 17. Review. Erratum in: Mov Disord. 2019 May;34(5):765.

PMID:
30653247
10.

Structural Imaging in Atypical Parkinsonism.

Heim B, Krismer F, Seppi K.

Int Rev Neurobiol. 2018;142:67-148. doi: 10.1016/bs.irn.2018.08.010. Epub 2018 Sep 24. Review.

PMID:
30409261
11.

Diagnosis of PSP-P: Can a newly developed MRPI make the difference?

Krismer F, Seppi K.

Parkinsonism Relat Disord. 2018 Sep;54:1-2. doi: 10.1016/j.parkreldis.2018.09.009. Epub 2018 Sep 13. No abstract available.

PMID:
30236828
12.

Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional Study.

Peball M, Mahlknecht P, Werkmann M, Marini K, Murr F, Herzmann H, Stockner H, de Marzi R, Heim B, Djamshidian A, Willeit P, Willeit J, Kiechl S, Valent D, Krismer F, Wenning GK, Nocker M, Mair K, Poewe W, Seppi K.

Gerontology. 2019;65(3):216-228. doi: 10.1159/000492572. Epub 2018 Sep 10.

PMID:
30199864
13.

Movement disorder society criteria for clinically established early Parkinson's disease.

Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schäffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB.

Mov Disord. 2018 Oct;33(10):1643-1646. doi: 10.1002/mds.27431. Epub 2018 Aug 25.

PMID:
30145841
14.

Validation of the MDS clinical diagnostic criteria for Parkinson's disease.

Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D.

Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.

PMID:
30145797
15.

Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy.

Krismer F, Seppi K, Wenning GK, Papapetropoulos S, Abler V, Goebel G, Schocke M, Poewe W.

Parkinsonism Relat Disord. 2019 Jan;58:23-27. doi: 10.1016/j.parkreldis.2018.08.004. Epub 2018 Aug 7.

PMID:
30145124
16.

Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study.

Borm CDJM, Krismer F, Wenning GK, Seppi K, Poewe W, Pellecchia MT, Barone P, Johnsen EL, Østergaard K, Gurevich T, Djaldetti R, Sambati L, Cortelli P, Petrović I, Kostić VS, Brožová H, Růžička E, Marti MJ, Tolosa E, Canesi M, Post B, Nonnekes J, Bloem BR; European MSA Study Group (EMSA-SG).

Parkinsonism Relat Disord. 2018 Nov;56:33-40. doi: 10.1016/j.parkreldis.2018.06.015. Epub 2018 Jun 8.

PMID:
29910157
17.

Reader response: Olfaction and incident Parkinson disease in US white and black older adults.

Mahlknecht P, Kiechl S, Willeit J, Poewe W, Seppi K.

Neurology. 2018 May 15;90(20):940. doi: 10.1212/WNL.0000000000005511. No abstract available.

PMID:
29759998
18.

Sensor-based gait analysis in atypical parkinsonian disorders.

Raccagni C, Gaßner H, Eschlboeck S, Boesch S, Krismer F, Seppi K, Poewe W, Eskofier BM, Winkler J, Wenning G, Klucken J.

Brain Behav. 2018 Jun;8(6):e00977. doi: 10.1002/brb3.977. Epub 2018 May 7.

19.

The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.

Mueller C, Hussl A, Krismer F, Heim B, Mahlknecht P, Nocker M, Scherfler C, Mair K, Esterhammer R, Schocke M, Wenning GK, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2018 Sep;54:90-94. doi: 10.1016/j.parkreldis.2018.04.005. Epub 2018 Apr 3.

20.

Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients.

Skorvanek M, Martinez-Martin P, Kovacs N, Zezula I, Rodriguez-Violante M, Corvol JC, Taba P, Seppi K, Levin O, Schrag A, Aviles-Olmos I, Alvarez-Sanchez M, Arakaki T, Aschermann Z, Benchetrit E, Benoit C, Bergareche-Yarza A, Cervantes-Arriaga A, Chade A, Cormier F, Datieva V, Gallagher DA, Garretto N, Gdovinova Z, Gershanik O, Grofik M, Han V, Kadastik-Eerme L, Kurtis MM, Mangone G, Martinez-Castrillo JC, Mendoza-Rodriguez A, Minar M, Moore HP, Muldmaa M, Mueller C, Pinter B, Poewe W, Rallmann K, Reiter E, Rodriguez-Blazquez C, Singer C, Valkovic P, Goetz CG, Stebbins GT.

Parkinsonism Relat Disord. 2018 Jul;52:83-89. doi: 10.1016/j.parkreldis.2018.03.027. Epub 2018 Mar 28.

PMID:
29625875
21.

International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.

Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, Coelho M, Sampaio C; Movement Disorder Society Evidence-Based Medicine Committee.

Mov Disord. 2018 Aug;33(8):1248-1266. doi: 10.1002/mds.27372. Epub 2018 Mar 23. Review. Erratum in: Mov Disord. 2018 Dec;33(12):1992.

PMID:
29570866
22.

Shaker-related voltage-gated potassium channels Kv1 in human hippocampus.

Willis M, Leitner I, Seppi K, Trieb M, Wietzorrek G, Marksteiner J, Knaus HG.

Brain Struct Funct. 2018 Jul;223(6):2663-2671. doi: 10.1007/s00429-018-1653-x. Epub 2018 Mar 21.

PMID:
29564531
23.

Cannabinoids for Treatment of Dystonia in Huntington's Disease.

Saft C, von Hein SM, Lücke T, Thiels C, Peball M, Djamshidian A, Heim B, Seppi K.

J Huntingtons Dis. 2018;7(2):167-173. doi: 10.3233/JHD-170283.

PMID:
29562549
24.

Reflection impulsivity perceptual decision-making in patients with restless legs syndrome.

Heim B, Pertl MT, Stefani A, Heidbreder A, Zamarian L, Brandauer E, Averbeck B, Delazer M, Seppi K, Högl B, Poewe W, Djamshidian A.

Ann Clin Transl Neurol. 2018 Jan 30;5(3):315-322. doi: 10.1002/acn3.535. eCollection 2018 Mar.

25.

Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.

Seki M, Seppi K, Mueller C, Potrusil T, Goebel G, Reiter E, Nocker M, Steiger R, Wildauer M, Gizewski ER, Wenning GK, Poewe W, Scherfler C.

Parkinsonism Relat Disord. 2018 Apr;49:81-87. doi: 10.1016/j.parkreldis.2018.02.004. Epub 2018 Feb 7.

PMID:
29463454
26.

The reorganization of functional architecture in the early-stages of Parkinson's disease.

Tuovinen N, Seppi K, de Pasquale F, Müller C, Nocker M, Schocke M, Gizewski ER, Kremser C, Wenning GK, Poewe W, Djamshidian A, Scherfler C, Seki M.

Parkinsonism Relat Disord. 2018 May;50:61-68. doi: 10.1016/j.parkreldis.2018.02.013. Epub 2018 Feb 8.

PMID:
29449186
27.

Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.

Mahlknecht P, Gasperi A, Djamshidian A, Kiechl S, Stockner H, Willeit P, Willeit J, Rungger G, Poewe W, Seppi K.

Mov Disord. 2018 Mar;33(3):405-413. doi: 10.1002/mds.27281. Epub 2018 Feb 13.

PMID:
29436728
28.

Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis.

Bajaj S, Krismer F, Palma JA, Wenning GK, Kaufmann H, Poewe W, Seppi K.

PLoS One. 2017 Dec 29;12(12):e0189897. doi: 10.1371/journal.pone.0189897. eCollection 2017. Review.

29.

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Walsh RR, Krismer F, Galpern WR, Wenning GK, Low PA, Halliday G, Koroshetz WJ, Holton J, Quinn NP, Rascol O, Shaw LM, Eidelberg D, Bower P, Cummings JL, Abler V, Biedenharn J, Bitan G, Brooks DJ, Brundin P, Fernandez H, Fortier P, Freeman R, Gasser T, Hewitt A, Höglinger GU, Huentelman MJ, Jensen PH, Jeromin A, Kang UJ, Kaufmann H, Kellerman L, Khurana V, Klockgether T, Kim WS, Langer C, LeWitt P, Masliah E, Meissner W, Melki R, Ostrowitzki S, Piantadosi S, Poewe W, Robertson D, Roemer C, Schenk D, Schlossmacher M, Schmahmann JD, Seppi K, Shih L, Siderowf A, Stebbins GT, Stefanova N, Tsuji S, Sutton S, Zhang J.

Neurology. 2018 Jan 9;90(2):74-82. doi: 10.1212/WNL.0000000000004798. Epub 2017 Dec 13. Review.

30.

MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.

Mangesius S, Hussl A, Krismer F, Mahlknecht P, Reiter E, Tagwercher S, Djamshidian A, Schocke M, Esterhammer R, Wenning G, Müller C, Scherfler C, Gizewski ER, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2018 Jan;46:47-55. doi: 10.1016/j.parkreldis.2017.10.020. Epub 2017 Oct 31.

31.

Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.

Iranzo A, Santamaría J, Valldeoriola F, Serradell M, Salamero M, Gaig C, Niñerola-Baizán A, Sánchez-Valle R, Lladó A, De Marzi R, Stefani A, Seppi K, Pavia J, Högl B, Poewe W, Tolosa E, Lomeña F.

Ann Neurol. 2017 Sep;82(3):419-428. doi: 10.1002/ana.25026.

PMID:
28833467
32.

Insulin signalling: new target for Parkinson's treatments?

Poewe W, Seppi K.

Lancet. 2017 Oct 7;390(10103):1628-1630. doi: 10.1016/S0140-6736(17)32101-3. Epub 2017 Aug 3. No abstract available.

PMID:
28781109
33.

Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.

Ofori E, Krismer F, Burciu RG, Pasternak O, McCracken JL, Lewis MM, Du G, McFarland NR, Okun MS, Poewe W, Mueller C, Gizewski ER, Schocke M, Kremser C, Li H, Huang X, Seppi K, Vaillancourt DE.

Mov Disord. 2017 Oct;32(10):1457-1464. doi: 10.1002/mds.27100. Epub 2017 Jul 17.

34.

Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues.

Classen J, Koschel J, Oehlwein C, Seppi K, Urban P, Winkler C, Wüllner U, Storch A.

J Neural Transm (Vienna). 2017 Aug;124(8):1029-1036. doi: 10.1007/s00702-017-1757-0. Epub 2017 Jul 12. Review.

PMID:
28702850
35.

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3.

36.

Very late-onset pure autonomic failure.

Fanciulli A, Stefanova N, Scherfler C, Moser P, Seppi K, Gizewski ER, Virgolini I, Boesch S, Poewe W, Wenning GK.

Mov Disord. 2017 Jul;32(7):1106-1108. doi: 10.1002/mds.27020. Epub 2017 Apr 24. No abstract available.

37.

Haste makes waste: Decision making in patients with restless legs syndrome with and without augmentation.

Heim B, Pertl MT, Stefani A, Delazer M, Heidbreder A, Zamarian L, Brandauer E, Seppi K, Högl B, Poewe W, Djamshidian A.

PLoS One. 2017 Apr 5;12(4):e0174793. doi: 10.1371/journal.pone.0174793. eCollection 2017.

38.

Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Heim B, Krismer F, De Marzi R, Seppi K.

J Neural Transm (Vienna). 2017 Aug;124(8):915-964. doi: 10.1007/s00702-017-1717-8. Epub 2017 Apr 4. Review.

39.

The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.

Lehericy S, Vaillancourt DE, Seppi K, Monchi O, Rektorova I, Antonini A, McKeown MJ, Masellis M, Berg D, Rowe JB, Lewis SJG, Williams-Gray CH, Tessitore A, Siebner HR; International Parkinson and Movement Disorder Society (IPMDS)-Neuroimaging Study Group.

Mov Disord. 2017 Apr;32(4):510-525. doi: 10.1002/mds.26968. Epub 2017 Mar 28. Review.

PMID:
28370449
40.

Parkinson disease.

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE.

Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13. Review.

PMID:
28332488
41.

IgLON5 autoimmunity tested negative in patients with progressive supranuclear palsy and corticobasal syndrome.

Mangesius S, Sprenger F, Höftberger R, Seppi K, Reindl M, Poewe W.

Parkinsonism Relat Disord. 2017 May;38:102-103. doi: 10.1016/j.parkreldis.2017.03.002. Epub 2017 Mar 6. No abstract available.

PMID:
28285943
42.

Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked.

Ekker MS, Janssen S, Seppi K, Poewe W, de Vries NM, Theelen T, Nonnekes J, Bloem BR.

Parkinsonism Relat Disord. 2017 Jul;40:1-10. doi: 10.1016/j.parkreldis.2017.02.014. Epub 2017 Feb 21. Review.

PMID:
28284903
43.

Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration.

Skorvanek M, Martinez-Martin P, Kovacs N, Rodriguez-Violante M, Corvol JC, Taba P, Seppi K, Levin O, Schrag A, Foltynie T, Alvarez-Sanchez M, Arakaki T, Aschermann Z, Aviles-Olmos I, Benchetrit E, Benoit C, Bergareche-Yarza A, Cervantes-Arriaga A, Chade A, Cormier F, Datieva V, Gallagher DA, Garretto N, Gdovinova Z, Gershanik O, Grofik M, Han V, Huang J, Kadastik-Eerme L, Kurtis MM, Mangone G, Martinez-Castrillo JC, Mendoza-Rodriguez A, Minar M, Moore HP, Muldmaa M, Mueller C, Pinter B, Poewe W, Rallmann K, Reiter E, Rodriguez-Blazquez C, Singer C, Tilley BC, Valkovic P, Goetz CG, Stebbins GT.

Mov Disord Clin Pract. 2017 Mar 11;4(4):536-544. doi: 10.1002/mdc3.12476. eCollection 2017 Jul-Aug.

44.

Letter re: Incident parkinsonism in older adults without Parkinson disease.

Mahlknecht P, Kiechl S, Willeit J, Poewe W, Seppi K.

Neurology. 2017 Feb 28;88(9):919. doi: 10.1212/WNL.0000000000003671. No abstract available.

PMID:
28242850
45.

Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease.

Mahlknecht P, Krismer F, Poewe W, Seppi K.

Mov Disord. 2017 Apr;32(4):619-623. doi: 10.1002/mds.26932. Epub 2017 Feb 2.

PMID:
28151553
46.

Augmentation and impulsive behaviors in restless legs syndrome: Coexistence or association?

Nirenberg MJ, Djamshidian A, Heim B, Högl B, Seppi K, Poewe W.

Neurology. 2016 Dec 13;87(24):2603. No abstract available.

PMID:
27956569
47.

Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.

Krismer F, Pinter B, Mueller C, Mahlknecht P, Nocker M, Reiter E, Djamshidian-Tehrani A, Boesch SM, Wenning GK, Scherfler C, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2017 Feb;35:36-41. doi: 10.1016/j.parkreldis.2016.11.010. Epub 2016 Nov 21.

PMID:
27890451
48.

Topography of Dopamine Transporter Availability in the Cerebellar Variant of Multiple System Atrophy.

Nocker M, Seppi K, Boesch S, Donnemiller E, Virgolini I, Wenning GK, Poewe W, Scherfler C.

Mov Disord Clin Pract. 2016 Nov 2;4(3):389-396. doi: 10.1002/mdc3.12446. eCollection 2017 May-Jun.

49.

Genome-wide association study in essential tremor identifies three new loci.

Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G, Rouleau GA.

Brain. 2016 Dec;139(Pt 12):3163-3169. Epub 2016 Oct 20.

50.

Consistency of "Probable RBD" Diagnosis with the RBD Screening Questionnaire: A Follow-up Study.

Stefani A, Mahlknecht P, Seppi K, Nocker M, Mair KJ, Hotter A, Stockner H, Willeit J, Kiechl S, Rungger G, Gasperi A, Poewe W, Högl B.

Mov Disord Clin Pract. 2016 Nov 1;4(3):403-405. doi: 10.1002/mdc3.12448. eCollection 2017 May-Jun.

Supplemental Content

Support Center